CURE Pharmaceutical

CURE Pharmaceutical is a private, commercial-stage drug delivery company leveraging its proprietary CUREfilm® oral film technology to reformulate existing therapeutics and nutraceuticals. The company operates an FDA-registered cGMP manufacturing facility and holds a significant IP portfolio with over 40 issued and pending US patents. Its strategic focus areas include erectile dysfunction, diabetes, weight management, vaccines, and nutraceuticals, targeting improved patient outcomes through enhanced bioavailability and convenience.

CUREfilm®: A patented orodispersible film for sublingual/buccal delivery that improves drug absorption by avoiding first-pass metabolism, enables precise dosing, and enhances patient compliance through convenience and ease of use.

CURE competes in the drug delivery sector with other firms developing oral film technologies (e.g., Aquestive Therapeutics) and novel oral delivery platforms. It also competes indirectly with injectable and traditional oral solid dosage forms, aiming to displace them by offering improved bioavailability and patient experience.